RadNet CEO Howard Berger Sells Company Shares
RadNet's CEO Howard Berger recently sold 90 shares of the company.
Key Points
- RadNet's CEO, Howard Berger, sold 90 shares on June 16, 2026, as an unplanned transaction.
- RadNet trades on NasdaqGM under the ticker RDNT, with a current price of $52.82 and a market cap of $4.15 billion.
- The company operates in healthcare diagnostics, with a negative EPS and a forward P/E ratio of 55.99.
Important disclosure: EarningsIQ is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 16, 2026, Howard Berger, the President and CEO of RadNet, Inc., sold 90 shares of the company. This transaction was not part of a pre-planned trading program. RadNet trades on the NasdaqGM under the ticker RDNT.
RadNet, Inc. Stock Holds Steady
Shares of NasdaqGM:RDNT are trading near $52.82. RadNet, Inc. has a market cap of approximately $4.15 billion. The company has a forward P/E ratio of 55.99 and a beta of 1.385, indicating a somewhat higher volatility compared to the market. The stock's 52-week range is between $50.76 and $85.84, with a 50-day moving average of $56.00 and a 200-day moving average of $68.41. RadNet also has a current ratio of 1.165 and a quick ratio of 1.049, suggesting moderate liquidity, while its debt-to-equity ratio stands at 142.999.
$RDNT stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
In its latest financial results, RadNet reported revenue of approximately $2.14 billion, showing a growth rate of 22.1%. Despite this, the company posted a negative net margin of 0.662% and a return on equity of 1.77%, reflecting ongoing challenges in profitability. The next earnings report is expected on August 6, 2026.
About RadNet, Inc.
RadNet, Inc. is a healthcare company based in Los Angeles, California, that provides outpatient diagnostic imaging services. The company operates through its Imaging Centers and Digital Health segments, offering a range of services such as MRI, CT scans, PET scans, and other imaging procedures. RadNet also develops AI-powered health informatics solutions to enhance radiology services. Founded in 1981, it employs around 11,000 people.
Bottom Line
Howard Berger's sale of RadNet shares is a notable event for investors tracking insider activities. RadNet operates in the dynamic healthcare diagnostics sector, which is reflected in its stock's volatility and the company's financial performance. As a reminder, insider transactions like this are disclosed after the fact and are not necessarily indicative of future performance.
Get RadNet, Inc. alerts
New 13F filings, insider trades, and analyst moves on $RDNT, sent to your inbox. Free, and you can unsubscribe anytime.
Related Filing Alerts
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.
S